Oncotelic Therapeutics, Inc.·4

Aug 29, 9:15 AM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed Aug 29, 2022

Insider Transaction Report

Form 4
Period: 2022-08-25
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2022-08-25$0.08/sh+80,000$6,56090,348,021 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    6,872,529
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384

Documents

1 file
  • 4
    ownership.xmlPrimary